SAM
ANIK icon

Shell Asset Management’s Anika Therapeutics ANIK Stock Holding History

Shell Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,332
Closed -$14K – 1153
2025
Q2 		$14K Sell
1,332
-980
-42% -$12.4K ﹤0.01% 1243
2025
Q1 		$35K Sell
2,312
-97
-4% -$1.61K ﹤0.01% 1197
2024
Q4 		$40K Hold
2,409
– – ﹤0.01% 1199
2024
Q3 		$60K Buy
+2,409
New +$62.5K ﹤0.01% 1154
2024
Q1 		$64K Sell
2,545
-176
-6% -$4.26K ﹤0.01% 1115
2023
Q4 		$62K Sell
2,721
-779
-22% -$16.1K ﹤0.01% 1139
2023
Q3 		$65K Sell
3,500
-54
-2% -$1.12K ﹤0.01% 1158
2023
Q2 		$92K Sell
3,554
-21
-0.6% -$562 ﹤0.01% 1136
2023
Q1 		$103K Sell
3,575
-12
-0.3% -$357 ﹤0.01% 1095
2022
Q4 		$106K Sell
3,587
-354
-9% -$10.1K ﹤0.01% 1141
2022
Q3 		$94K Sell
3,941
-515
-12% -$11.9K ﹤0.01% 1251
2022
Q2 		$99K Buy
4,456
+57
+1% +$1.27K ﹤0.01% 1281
2022
Q1 		$110K Sell
4,399
-650
-13% -$19.8K ﹤0.01% 1279
2021
Q4 		$181K Buy
5,049
+29
+0.6% +$1.16K ﹤0.01% 1229
2021
Q3 		$214K Sell
5,020
-220
-4% -$9.06K ﹤0.01% 1183
2021
Q2 		$227K Sell
5,240
-3,681
-41% -$157K ﹤0.01% 1199
2021
Q1 		$364K Buy
8,921
+5,117
+135% +$194K 0.01% 975
2020
Q4 		$172K Hold
3,804
– – ﹤0.01% 1156
2020
Q3 		$135K Hold
3,804
– – ﹤0.01% 1120
2020
Q2 		$144K Buy
+3,804
New +$125K ﹤0.01% 1092

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Shell Asset Management's ANIK Position: Q3 2025 in Review

Shell Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2025, closing a stake of 1,332 shares — an estimated $14K sold.

Shell Asset Management first reported a position in ANIK in Q2 2020 and held it in 20 quarters. The position peaked at $364K in Q1 2021. 117 funds tracked by Wall St. Rank hold ANIK as of Q3 2025.

  • Shell Asset Management reported no remaining Anika Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Shell Asset Management sold 1,332 Anika Therapeutics shares in Q3 2025, an estimated $14K.
  • Shell Asset Management first reported a position in Anika Therapeutics in Q2 2020 and held it in 20 quarters.
  • Shell Asset Management's Anika Therapeutics position peaked at $364K in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.